InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Weissman James B, Chief Operating Officer. Director active across 2 companies, notably Dicerna Pharmaceuticals Inc. Aggregated, 7 filings have been recorded. History available since 6 July 2021. The latest transaction was filed on 24 July 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
8,390 shares0Common StockSEC:0000950170-24-086881:0
18,100 shares@ US$38.2536.3% of flowCommon StockSEC:0001399529-21-000205
18,100 shares@ US$38.2536.3% of flowCommon StockSEC:0001399529-21-000205:0
3,775 sharesCommon StockSEC:0001399529-21-000175:0
3,775 sharesCommon StockSEC:0001399529-21-000175
30,000 shares@ US$9.0913.7% of flowCommon StockSEC:0001399529-21-000132
30,000 shares@ US$9.0913.7% of flowCommon StockSEC:0001399529-21-000132:0
7 of 7 declarations
About Weissman James B
James B. Weissman is the Chief Operating Officer and Executive Vice President at Dicerna Pharmaceuticals Inc. He oversees the company's operations and is responsible for implementing operational strategies. With significant experience in the biopharmaceutical sector, he plays a key role in Dicerna's growth and innovation. His leadership is essential in achieving the company's objectives.
